CHSN
Chanson International Holding
There isn't enough reported data to score CHSN yet.
GME
GameStop Corp.
GME's fundamentals are strong: its operating margin rose 11 points to 14% and it turned 19% of its revenue into free cash flow, though revenue fell 7.7%. At 17x earnings, it's trading less than half its usual 44x. Analysts expect earnings to fall sharply.
CHSN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
CHSN's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
CHSN PE Valuation
CHSN has no meaningful PE right now: it lost money over the past year.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.
CHSN Forward outlook
There aren't enough analyst estimates for CHSN to show an outlook.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
CHSN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $400.00 | +1567% |
CHSN and GME do not have enough comparable growth data to identify a winner.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.
CHSN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.3M | -4.5% |
| Q4 2025 | $9.6M | -10% |
| Q2 2025 | $8.7M | +15% |
| Q4 2024 | $10.7M | +27% |
| Q2 2024 | $7.5M | -14% |
| Q4 2023 | $8.4M | +79% |
| Q2 2023 | $8.8M | +3.1% |
| Q4 2022 | $4.7M | -41% |
CHSN has the edge over GME in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -9.4% | -2 points |
| Q4 2025 | -7.3% | +1.3 points |
| Q2 2025 | -14% | -15 points |
| Q4 2024 | 0.3% | +32 points |
| Q2 2024 | -7.4% | -6.9 points |
| Q4 2023 | -8.6% | -4.6 points |
| Q2 2023 | 1.3% | +5.3 points |
| Q4 2022 | -32% | -20 points |
CHSN's operating margin was −9.4% last quarter, down 2 points from the same quarter a year ago.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME has the edge over CHSN on profitability, with a higher operating margin.
CHSN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $2.2M | +$6.4M |
| Q2 2024 | $771.9K | +68% |
| Q4 2023 | -$4.2M | -778% |
| Q2 2023 | $458.1K | +$1.4M |
| Q4 2022 | $617.7K | +$1M |
| Q2 2022 | -$926.4K | -738% |
| Q4 2021 | -$405.1K | -164% |
| Q2 2021 | $145.3K | +263% |
CHSN's free cash flow was −$4M over the past year, against −$255,670 the year before.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME generated $688M in free cash flow over the past year, up 43% from the year before.
CHSN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +85094% | +1.3M shares |
| 1 year | +730% | +1.2M shares |
CHSN has 1M diluted shares, up 730% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
| Q4 2019 | — |
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has the edge over CHSN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
CHSN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -36.0x | Net Cash |
CHSN has more cash than debt.
GME Net Leverage
CHSN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 35.1 | Neutral |
CHSN's weekly RSI is 33 (neutral) and its Stochastic is 35 (neutral).
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
CHSN PE vs Consumer Cyclical Sector
| Metric | CHSN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CHSN has no meaningful PE right now: it lost money over the past year.
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
CHSN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.25 | 52% below |
| 20 week MA | $1.15 | 48% below |
| 50 week MA | $92.1 | 99% below |
| 100 week MA | $3,017.9 | 100% below |
GME has stronger trend alignment. CHSN is above 0 of 4 weekly averages versus GME above 5 of 5.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME is in an uptrend: it's above all five of its weekly moving averages, and 17% above its 200-week average.
CHSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $16,880.0 | $9,760.0 | -42% |
| 2024 | $9,760.0 | $46,320.0 | +375% |
| 2025 | $46,320.0 | $209.0 | -100% |
| 2026 YTD | $209.0 | $0.60 | -100% |
CHSN's yearly returns have swung widely, from +375% in 2024 to −100% in 2025. It's down 100% so far in 2026.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over CHSN on returns for 2026, with the stronger performance.